Safety and reliability of telesurgery in China: a multicenter, single-arm, phase I clinical trial

Sheng Tai, Ye Wang, Sunyi Ye, Tao Xu, Gen Cheng, Cheng Yang, Hongzhi Wang, Haibing Xiao, Qingbo Huang, Shuo Wang, Xiangping Zhang, Jianle Mao, Nan Qiao, Zongyao Hao, Dan Xia, Wanhai Xu, Xu Zhang, Chang Yin LiangInternational Journal of Surgery 2025 · DOI

TL;DR

This paper presents a multicenter clinical trial demonstrating the safety and feasibility of a novel telesurgery system in China. The system, utilizing 5G and dedicated line technology, successfully enabled robot-assisted laparoscopic surgeries across significant distances, paving the way for improved access to specialized surgical care in remote areas.

What Problem Does This Paper Address?

The paper tackles the critical challenge of unequal distribution of advanced medical resources, particularly specialized surgical care, between urban and rural or remote regions. Traditional surgery requires patients to travel to specialized centers, which is often impractical or impossible for those in underserved areas. The COVID-19 pandemic further highlighted the need for remote healthcare solutions. Telesurgery, the remote performance of surgical procedures using robotic systems and telecommunication networks, offers a potential solution by bridging geographical barriers. However, the practical implementation of telesurgery has been historically limited by the capabilities of robotic systems and, crucially, the reliability and latency of telecommunication networks. This study aims to address these limitations by evaluating a new telesurgery system designed for seamless network switching and optimized signal processing in a real-world clinical setting.

Methods

The study employed a multicenter, single-arm, phase I clinical trial design involving 18 patients across four hospitals in China. The core of the research is a novel telesurgery system that integrates four key components: a surgeon console, a bedside operating system, a teleconference system, and a telecommunications system.

Key innovations in the system include:

  • Telesurgery Host with Advanced Signal Processing: Surgical signals are aggregated and optimized at a "telesurgery host." This host utilizes real-time signal processing and multi-source signal interaction systems. These systems incorporate techniques like ultra-low latency codec optimization, 2K/4K 3D video resolution compatibility, adaptive bitrate and resolution adjustment, forward error correction, network jitter buffering, and region-of-interest (ROI)-adaptive network adjustment.
  • Telesurgery Network Solution: To ensure seamless operation across varying network conditions, a dedicated telesurgery network solution was developed. This solution supports the coexistence of three network types (dedicated line, commercial broadband, and 5G) and enables seamless switching between them, along with hot standby capabilities and multi-point interconnectivity.
  • Standardized Surgical Procedures: The study focused on robot-assisted laparoscopic partial nephrectomy and radical prostatectomy, common urologic oncology procedures.

Datasets

Not discussed in the paper. The study involved direct patient data from clinical surgeries.

Key Insights and Ideas

  • 100% Telesurgery Success Rate: The most striking finding is the complete success rate of all telesurgeries performed, indicating the system's high reliability in a clinical setting.
  • Latency is Manageable: Despite significant distances (up to 2200 km), the measured network latencies were well within acceptable ranges for surgical performance, aligning with previous research suggesting a <200 ms threshold. This suggests that the signal processing and network solutions effectively mitigated potential issues.
  • Network Stability Across Distances: Crucially, key network parameters like jitter, video encoding/decoding latency, code rate, and video display latency remained stable across different city pairs and did not significantly fluctuate with increasing geographical distance. This highlights the robustness of the telesurgery network solution.
  • Low Surgeon Workload: Subjective assessments using the NASA-TLX and other questionnaires indicated that telesurgery did not impose a significant additional workload on surgeons, and the overall surgical process was rated as relatively smooth. This is vital for surgeon adoption and long-term sustainability.
  • Feasibility for Urologic Oncology: The study successfully demonstrated the application of telesurgery for specific urologic oncology procedures, suggesting its potential as a viable treatment option for patients in remote areas.

Key Results

  • Telesurgery Success Rate: 100% of the 18 patients successfully underwent telesurgery.
  • Network Latency: Mean real-time round-trip network latency was 38.38 ± 13.25 ms.
  • Video Encoding/Decoding Latency: 20.02 ± 0.06 ms.
  • Network Jitter: 0.39 ± 0.29 ms.
  • Frame Loss: No frame loss occurred during any telesurgeries.
  • Code Rate: 12.77 ± 0.57 Mbps.
  • Video Display Latency: 21.35 ± 3.42 ms.
  • Operative Times: Mean operative time for partial nephrectomy was 127.4 ± 37.9 min, and for prostatectomy was 167.8 ± 30.0 min.
  • Postoperative Complications: Low rates of complications were observed (28.6% for partial nephrectomy, 18.2% for prostatectomy), primarily mild fever and infection.
  • Surgeon Subjective Evaluation: 96% of items in workload assessments were rated as 4 or 5 (somewhat possible to possible), indicating a positive subjective experience.

Limitations and Future Work

The authors acknowledge several limitations:

  • Small Sample Size: The study included only 18 patients, which is a small sample size for a phase I trial.
  • Single-Arm Design: The study was a single-arm trial, meaning there was no control group for comparison.
  • Potential for Bias: Patient awareness and varying surgeon experiences could have influenced hospital duration.

The authors suggest that future work should involve:

  • Larger-Scale Trials: Conducting trials with a larger number of patients.
  • Diverse Surgical Procedures: Expanding the application to a wider range of surgical procedures and specialties.
  • Comparative Studies: Including control groups to further validate the efficacy and safety of telesurgery compared to traditional methods.
  • Long-Term Follow-up: Continued monitoring of patients for long-term outcomes.

Summary updated

Abstract

Our results indicated that telesurgery using 5G and dedicated line technology was a safe and feasible treatment option for patients with urologic oncology.
BibTeX
@article{tai2025safety,
  author = {Sheng Tai and Ye Wang and Sunyi Ye and Tao Xu and Gen Cheng and Cheng Yang and Hongzhi Wang and Haibing Xiao and Qingbo Huang and Shuo Wang and Xiangping Zhang and Jianle Mao and Nan Qiao and Zongyao Hao and Dan Xia and Wanhai Xu and Xu Zhang and Chang Yin Liang},
  title = {{Safety and reliability of telesurgery in China: a multicenter, single-arm, phase I clinical trial}},
  journal = {International Journal of Surgery},
  year = {2025},
  doi = {10.1097/js9.0000000000002792},
}
Figure